Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
14,89 USD | +1,43% | -1,59% | -11,42% |
Attività
Numero di dipendenti: 167
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Drug Products
100,0
%
| 214 | 100,0 % | 398 | 100,0 % | +85,90% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 214 | 100,0 % | 398 | 100,0 % | +85,90% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Patrick McEnany
FOU | Founder | 77 | 01/01/02 |
Richard Daly
CEO | Chief Executive Officer | 62 | 19/02/15 |
Michael Kalb
DFI | Director of Finance/CFO | 53 | 01/01 |
Stanley Iyadurai
CTO | Chief Tech/Sci/R&D Officer | - | 20/08/18 |
Brian Elsbernd
CMP | Compliance Officer | 60 | 29/02/16 |
Steven Miller
COO | Chief Operating Officer | 62 | 01/04/07 |
Gary Ingenito
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/06/15 |
Charles O'Keeffe
BRD | Director/Board Member | 84 | 01/12/04 |
Mary Coleman
IRC | Investor Relations Contact | - | 16/08/21 |
Preethi Sundaram
PRN | Corporate Officer/Principal | 47 | 06/07/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Patrick McEnany
FOU | Founder | 77 | 01/01/02 |
Donald Denkhaus
BRD | Director/Board Member | 78 | 19/02/15 |
David Tierney
BRD | Director/Board Member | 60 | 01/10/02 |
Charles O'Keeffe
BRD | Director/Board Member | 84 | 01/12/04 |
Richard Daly
CEO | Chief Executive Officer | 62 | 19/02/15 |
Molly Harper
BRD | Director/Board Member | 48 | 29/06/21 |
Tamar Thompson
BRD | Director/Board Member | 50 | 25/05/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 118 011 092 | 110 678 237 ( 93,79 %) | 0 | 93,79 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
1 414 688 | 11.21% | 15 345 290 $ |
Coordinate società
Catalyst Pharmaceuticals, Inc.
355 Alhambra Circle Suite 801
33134, Coral Gables
+305 420 3200
http://www.catalystpharma.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-11,42% | 1,76 Mrd | |
-4,66% | 86,13 Mrd | |
+1,32% | 39,82 Mrd | |
-19,27% | 30,42 Mrd | |
+57,86% | 25,23 Mrd | |
-16,09% | 15,35 Mrd | |
-9,14% | 11,95 Mrd | |
-17,69% | 11,6 Mrd | |
-43,00% | 11,51 Mrd | |
+5,24% | 8,71 Mrd |
- Borsa valori
- Azioni
- Azione CPRX
- Società Catalyst Pharmaceuticals, Inc.